Advanced Synthetic Strategies in Nanomedicine and Its Impact on Biological and Medical Applications
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Nanochemistry".
Deadline for manuscript submissions: closed (30 November 2024) | Viewed by 8000
Special Issue Editors
Interests: tumor biology; EPR effect; anticancer nanomedicine; nanotoxicology; micelles
Interests: nanomedicine; tumor-targeting; EPR effect; carbon monoxide; inflammation; reactive oxygen species
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanomedicine is an adaptive tool accommodating a rich background for scientific research and technological development, with the field expanding to areas such as novel approaches for cancer treatment, immunotherapy, vaccine development, gene delivery, and theranostic tools, to name a few.
The scope of the present Special Issue is to gain more insight into the versatile and adaptive nature of nanomedicine in biology and medical applications.
In this context, I invite researchers to submit their original communications, perspectives, and research and review articles on novel applications of nanomedicine, theranostic applications, solid-state nanoparticles, vaccine development, immunotherapy, tissue engineering, and cancer therapeutics.
Prof. Dr. Greish Khaled
Dr. Jun Fang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- novel applications of nanomedicine
- theranostic applications
- solid-state nanoparticles
- vaccine development
- immunotherapy
- gene delivery
- tissue engineering
- cancer therapeutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.